The approval is based on evidence that the vaccine can prevent anogenital infections, with an ongoing trial looking at throat infection prevention in men likely to be critical for continued approval.
Study authors compared clinical cure in patients with E coli bacteremic UTI who were stepped down to oral beta-lactams compared to oral fluoroquinolones.
Study authors assessed the efficacy and safety of cefiderocol vs best available therapy in adults with serious carbapenem-resistant Gram-negative infections.
Telehealth use in gastroenterology has significantly increased during the COVID-19 pandemic, with a high level of satisfaction among both patients and providers.
Emerging evidence indicates that gastrointestinal and hepatic manifestations may play an important role in COVID-19, but their prevalence and significance remain unknown.
Ibrexafungerp is an investigational oral antifungal agent representing a novel therapeutic class of structurally-distinct glucan synthase inhibitors known as triterpenoids.
Research authors assessed the safety and efficacy of intravesical bacteriophage therapy compared to placebo and current standard of care for the treatment of urinary tract infection in patients undergoing transurethral resection of the prostate.
Isolates were clustered based on patient sexual behavior and race/ethnicity to assess antibiotic resistance as a major driver of gonorrhea transmission in NYC.
Data from the pivotal phase 3 trial demonstrated clinically and statistically significant microbiological cure compared with placebo at the test of cure visit.
For patients with gonorrhea, detection of the wild-type serine 91 genotype of the gyrA gene of Neisseria gonorrhoeae is predictive of a successful treatment outcome with ciprofloxacin.
